Coeptis Therapeutics Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Coeptis Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2019 to Q1 2022.
  • Coeptis Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $1.13M, a 54.7% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $8.22M, a 183% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.13M -$1.36M -54.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q1 2021 $2.49M +$987K +65.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $1.5M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
Q3 2019 $99.00* Apr 30, 2019 Aug 31, 2019 10-Q/A 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.